The latest arrival of Tirzepatide 40mg represents a seemingly significant advancement in the approach of type 2 the condition . This drug builds upon the prior success of lower strengths , showing encouraging results in lowering blood glycemic control and aiding weight loss . Clinicians are exploring its full effect on heart outcomes and associated